Propyl Gallate

Propyl Gallate

SCHEMBL3147225

CCCOC(=O)c1cc(O)c(O)c(O)c1.OCC(O)CO

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 7/20 0.65
SERPINE1 P05121 5/20 0.62
AKR1C4 P17516 1/20 0.61
AKR1C3 P42330 1/20 0.61
AKR1C2 P52895 1/20 0.61
AKR1C1 Q04828 1/20 0.61
TYR P14679 2/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
ALDH1A1 P00352 1/20 0.49
CHRM1 P11229 1/20 0.49
TSHR P16473 1/20 0.49
SLC6A2 P23975 1/20 0.49
KDR P35968 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
KDM4E B2RXH2 1/20 0.48
POLB P06746 1/20 0.48
LMNA P02545 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propyl Gallate SCHEMBL1728841 0.92 ESR1 (0.58) ESR1SERPINE1AKR1C4AKR1C3AKR1C2
Propyl Gallate SCHEMBL1429770 0.91 ESR1 (0.65) ESR1SERPINE1AKR1C4AKR1C3AKR1C2
Propyl Gallate SCHEMBL6427209 0.89 ESR1 (0.75) ESR1SERPINE1AKR1C4AKR1C3AKR1C2
Propyl Gallate SCHEMBL788397 0.89 ESR1 (0.80) ESR1SERPINE1AKR1C4AKR1C3AKR1C2
Propyl Gallate SCHEMBL22630 0.89 ESR1 (0.80) ESR1SERPINE1AKR1C4AKR1C3AKR1C2
Propyl Gallate SCHEMBL16585562 0.88 ESR1 (0.61) ESR1SERPINE1AKR1C4AKR1C3AKR1C2
Propyl Gallate SCHEMBL16678445 0.87 ESR1 (0.77) ESR1SERPINE1AKR1C4AKR1C3AKR1C2
Propyl Gallate SCHEMBL8334443 0.87 ESR1 (0.77) ESR1SERPINE1AKR1C4AKR1C3AKR1C2
Propyl Gallate SCHEMBL29910229 0.87 ESR1 (0.77) ESR1SERPINE1AKR1C4AKR1C3AKR1C2
Propyl Gallate SCHEMBL9389174 0.87 ESR1 (0.77) ESR1SERPINE1AKR1C4AKR1C3AKR1C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180313827-A1 BIOMOLECULE SEPARATION AND MODIFICATION OXFORD UNIVERSITY INNOVATION LTD. (GB) 2018-11-01 US disclosed
US-7687062-B2 Method for diagnosing colon cancer RNL BIO CO. LTD. (KR) 2010-03-30 US disclosed
US-20080032319-A1 detecting antigens; hybridoma cell lines; monoclonal antibodies; immunochromatography strip for detecting defensin-alpha 6 comprising plastic plate on which sample application pad, gold particle bound Def-12 alpha antibody immobilized on glass fiber filter, nitrocellulose membrane RNL BIO CO. LTD. (KR) 2008-02-07 US disclosed
US-5234732-A Tamper-indicating wrappers PHILIP MORRIS INC. (US) 1993-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180313827-A1 BIOMOLECULE SEPARATION AND MODIFICATION MAX, STAMBP, PHAX ESR1 2102/4885SERPINE1 564/4885AKR1C4 4413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.